Found 416 hits.
| 13 | Prodeus, A., Zhou, X., Maurer, M. Galli, S. J., and Carroll, M. C.+: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997: 390; 172-175. IF: 27.36 |
o.013
| 336 | Kocatürk, E.+, Kiziltac, U., Can, P., Öztas Kara, R., Erdem, T., Kiziltac, K., Sahillioglu, N., Gelincik, A., Maurer, M., and Weller, K.: Validation of the Turkish version of the urticaria control test: correlation with other tools and comparison between spontaneous and inducible chronic urticaria. World Allergy Organ. J. 2019: 12; 6-13. IF: TBD (IF 2018: 3.68) |
o.336
| 310(a) | Zuberbier, T.+, Maurer, M., and Church, M. K.: Reply to Wood et al. Response to comment on: The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy 2019: 74; 418-419 |
|
533. |
Bernstein, J. A.+, Giménez-Arnau, A., Maurer, M., Staubach, P., Barbier, N., Hua, E., Severin, T., Laires, P. A., and Balp, M.-M.: Why a complete response is the treatment aim in chronic spontaneous urticaria. J. Clin. Med. 2023: 12; 3561. IF: 3.00 |
o.533
| 22 | Paus, R.+, Müller-Röver, S., Van Der Veen, C., Maurer. M., Eichmüller, S., Ling, G., Hofmann, U., Foitzik, K., Mecklenburg, L., and Handjiski, B.: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J. Invest. Dermatol. 1999: 113; 523-532. IF: 4.9 |
o.022
| 143 | Krause, K., Feist, E., Fiene, M., Kallinich, T., and Maurer, M.+: Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. J. Allergy Clin. Immunol. 2012: 129; 848-850. IF: 12.04 |
|
184. |
Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., Amber, K. T., Didona, D., Hertl, M., Recke, A., Graßhoff, H., Hackel, A., Schumann, A., Riemekasten, G., Bieber, K., Sprow, G., Dan, J., Zillikens, D., Sezin, T., Christiano, A. M., Wolk, K., Sabat, R., Kridin, K., Werth, V. P., and Ludwig, R. J.+: Unmet medical needs in chronic, non-communicable inflammatory skin diseases. Front. Med. 2022: 9; 899857. IF: 8.10 |
r.184
|
542. |
Türk, M.*, Ertas, R.*, Sahiner, Ü. M., Kolkhir, P., Sekerel, B. E., Soyer, Ö., Avci, Atil, Atasoy, M., Özyurt, K., Türk, Y., Zeydan, E., and Maurer, M.+: In chronic spontaneous urticaria, complete response to antihistamine treatment is linked to low disease activity. Int. Arch. Allergy Immunol. 2023:184; 421-432. IF: 2.50 |
o.542
| 263 | Longhurst, H. J.+, Zanichelli, A., Caballero, T., Bouillet, L., Aberer, W., Maurer, M. Fain, O., Fabien, V., and Andresen, I.: Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey. Clin. Exp. Immunol. 2017: 188; 148-153. IF: 3.54 |
|
545. |
Richtig, G.+, Berger, M., Koeller, M., Richtig, M., Richtig, E., Scheffel, J., Maurer, M.+, and Siebenhaar, F.+: Perception, impact and use of Beall’s list by the scientific community – a bibliometric big data study. PLoS One 2023:18; e0287547. IF: 2.90 |
o.545